Depression is a common symptom in cancer patients, which is difficult to be detected and consequently to be treated. It deteriorates over the the course of cancer treatment, persists long after the end of therapy and influences negatively the quality of life . Aim: The purpose of the present study was to evaluate the levels of depression that experience patients undergoing chemotherapy. Method and material: The sample study included 159 patients with cancer, who received chemotherapy in one day-clinic department. Data was collected by using the self-completed questionnaire «Zung Self Rating Depression Scale» (SDS). Statistical analysis was carried out using t-test, Anova and SPSS-15. Results: From the 159 patients studied, percentage of 34% was men and 66% women. According to the level of depression, 67,7% experienced normal levels of depression, 21,5% mild, 10,2% moderate and 0,6% severe depression. The statistical analysis showed that patients >70 years old experienced higher levels of depression, compared to those of 001, as well as those who had a co-existing disease, p=0,029. Conclusions: Health professionals should be fully informed about depression and its dimensions. Early diagnosis of depression consists a matter of great importance for a medical treatment and planning of care based mainly on the personal needs of each individual.
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2019 All rights reserved. iMedPub LTD Last revised : July 16, 2019